Semarion

Startup

Semarion, a University of Cambridge spin-out, revolutionizes cell-based assays for drug discovery and life science through its proprietary SemaCyte® microcarrier platform which leverages novel materials physics for assay miniaturization, multiplexing, and automation.
www.semarion.com